Rubber....meet the road. NIH Grant edition

May 06 2013 Published by under NIH, NIH Budgets and Economics, NIH funding

It is all very well to read the tea leaves and to make inferences from what Program Officials are telling you, published paylines, the gossip at writedit's blog and your anguished colleagues.

But nothing like a little judicious searching at RePORTER and / or a review of SILK listings to let you know just what your favorite handful of ICs are up to.

Happy browsing.

Personally, my biggest takeaway is that I should have ignored all the doom and gloom about R21s last year and submitted a few of them.

7 responses so far

  • How does the number of R21s being awarded tell you anything about the success rate? All of the published statistical evidence indicates that R21s have consistently worse success rates than R01s.

  • drugmonkey says:

    It is not impossible that this observation reinforced some little-birdy comments from a PO or two.

  • miles says:

    What is lesser known at the moment: The NIH/NCI renews existing RO1s currently only for 3 months with an anticipated cut of 6% from last years funding level. Watch out for you coronaries if you open you award notice. You have to read the fine print on page 4 to understand what's going on.

  • drugmonkey says:

    Three *months*? Whaaaaaa????

  • Ewan says:

    Yep. And colleagues with funded 5-year R01s are getting them pulled after year 2: "you should reapply for continued funding."

  • drugmonkey says:

    WHAAAAATTTT????? What IC?

  • Dave says:

    Yep. And colleagues with funded 5-year R01s are getting them pulled after year 2: "you should reapply for continued funding"

    I call B.S. on this one.

Leave a Reply